Biallelic somatic inactivation of the mismatch repair gene MLH1 in a primary skin melanoma

被引:10
|
作者
Castiglia, D
Pagani, E
Alvino, E
Vernole, P
Marra, G
Cannavò, E
Jiricny, J
Zambruno, G
D'Atri, S
机构
[1] IRCCS, Ist Dermopat Immacolata, Pharmacol Lab, I-00167 Rome, Italy
[2] IRCCS, Ist Dermopat Immacolata, Mol Cell Biol Lab, I-00167 Rome, Italy
[3] CNR, Inst Neurobiol & Mol Med, Rome, Italy
[4] Univ Roma Tor Vergata, Dept Publ Hlth & Cell Biol, Rome, Italy
[5] Univ Zurich, Inst Med Radiobiol, Zurich, Switzerland
来源
GENES CHROMOSOMES & CANCER | 2003年 / 37卷 / 02期
关键词
D O I
10.1002/gcc.10193
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Inactivation of mismatch repair (MMR) genes has been linked to the hereditary nonpolyposis colon cancer syndrome and to a subset of sporadic cancers. A phenotypic characteristic of tumors with defective MMR is microsatellite instability (MSI). Although MSI has been reported in a proportion of cutaneous melanomas, inactivation of MMR genes in this tumor type has not been detected thus far. We recently described a human melanoma cell line, PR-Mel, and a cutaneous metastasis from the same patient, which displayed a MMR defect, and showed high MSI. Here we report that in the PR-Mel cell line both MLH1 alleles are somatically inactivated. One allele is lost through a chromosomal deletion of the region 3p21-24, whereas the remaining allele harbors a G --> A transition at position -1 of the acceptor splice site of intron 15, leading to the in-frame skipping of exon 16. The primary melanoma of the PR patient shows loss of heterozygosity at the BAT21 microsatellite marker, located in the MLH1 gene, and does not express the MLH1 and PMS2 proteins. Moreover, it harbors the same mutation detected in the PR-Mel cells. These results demonstrate that biallelic inactivation of MLH1 had occurred in the primary melanoma of the PR patient and suggest that disruption of MMR might have had a role in the development of the melanoma. This is the first report in which genetic defects leading to disruption of MMR function in a human melanoma have been identified. (C) 2003 Wiley-Liss, Inc.
引用
收藏
页码:165 / 175
页数:11
相关论文
共 50 条
  • [41] Estrogen enhances mismatch repair by induction of MLH1 expression via estrogen receptor-β
    Lu, Jun-yu
    Jin, Peng
    Gao, Wei
    Wang, De-zhi
    Sheng, Jian-qiu
    ONCOTARGET, 2017, 8 (24) : 38767 - 38779
  • [42] Hepatic Adenomas Caused by Somatic HNF1A Mutations in Children With Biallelic Mismatch Repair Gene Mutations
    Holter, Spring
    Pollett, Aaron
    Zogopoulos, George
    Kim, Hyeja
    Schwenter, Frank
    Asai, Kengo
    Gallinger, Steven
    Clendenning, Mark
    Steinbach, Gideon
    Jacobson, Angela
    Boycott, Kym M.
    GASTROENTEROLOGY, 2011, 140 (02) : 735 - 736
  • [43] MLH1 constitutional and somatic methylation in patients with MLH1 negative tumors fulfilling the revised Bethesda criteria
    Crucianelli, Francesca
    Tricarico, Rossella
    Turchetti, Daniela
    Gorelli, Greta
    Gensini, Francesca
    Sestini, Roberta
    Giunti, Laura
    Pedroni, Monica
    de Leon, Maurizio Ponz
    Civitelli, Serenella
    Genuardi, Maurizio
    EPIGENETICS, 2014, 9 (10) : 1431 - 1438
  • [44] Hypermutation in immunoglobulin variable genes from mice deficient in the MLH1 mismatch repair protein
    Phung, QH
    Winter, DB
    Gearhart, PJ
    FASEB JOURNAL, 1999, 13 (05): : A992 - A992
  • [45] MLH1 promoter hypermethylation predicts poorer prognosis in mismatch repair deficiency endometrial carcinomas
    Kaneko, Enami
    Sato, Naoki
    Sugawara, Tae
    Noto, Aya
    Takahashi, Kazue
    Makino, Kenichi
    Terada, Yukihiro
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2021, 32 (06) : e79
  • [46] A Cell-Free Assay for the Functional Analysis of Variants of the Mismatch Repair Protein MLH1
    Drost, Mark
    Zonneveld, Jose B. M.
    van Dijk, Linda
    Morreau, Hans
    Tops, Carli M.
    Vasen, Hans F. A.
    Wijnen, Juul T.
    de Wind, Niels
    HUMAN MUTATION, 2010, 31 (03) : 247 - 253
  • [47] Functional analysis of human MLH1 variants using yeast and in vitro mismatch repair assays
    Takahashi, Masanobu
    Shimodaira, Hideki
    Andreutti-Zaugg, Corinne
    Iggo, Richard
    Kolodner, Richard D.
    Ishioka, Chikashi
    CANCER RESEARCH, 2007, 67 (10) : 4595 - 4604
  • [48] The Bloom's syndrome protein (BLM) interacts with MLH1 but is not required for DNA mismatch repair
    Langland, G
    Kordich, J
    Creaney, J
    Goss, KH
    Lillard-Wetherell, K
    Bebenek, K
    Kunkel, TA
    Groden, J
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (32) : 30031 - 30035
  • [49] MLH1 Hypermethylation and BRAF Mutation Testing in Colorectal Cancer Patients with Mismatch Repair Defect
    Jin, M.
    Clendenning, M.
    Hampel, H.
    Frankel, W. L.
    MODERN PATHOLOGY, 2013, 26 : 158A - 158A
  • [50] Myc down-regulation sensitizes melanoma cells to radiotherapy by inhibiting MLH1 and MSH2 mismatch repair proteins
    Bucci, B
    D'Agnano, I
    Amendola, D
    Citti, A
    Raza, GH
    Miceli, R
    De Paula, U
    Marchese, R
    Albini, S
    Felsani, A
    Brunetti, E
    Vecchione, A
    CLINICAL CANCER RESEARCH, 2005, 11 (07) : 2756 - 2767